Answers are grounded in this paper and cite their sources.
This study demonstrates wastewater surveillance for monitoring carbapenem resistance, suggesting its significance in infection control.
Background Antimicrobial resistance (AMR) poses a growing threat to global public health and is a key concern for infection control teams in hospitals. However, AMR surveillance is time-consuming and limited in most countries, resulting in incomplete findings. In several high-income countries, infection control teams ensure the contact tracing of every patient carrying an emerging extremely resistant bacterium which is very time-consuming. Wastewater surveillance (WWS) has been proposed as an alternative approach for the surveillance of infectious diseases. This study aims to investigate the dynamics of endemic (blaCTX-M) and emerging AMR genes (blaOXA-48, blaNDM, blaKPC and vanA) in wastewater under real-world hospital conditions, and to compare results from two hospital buildings with contrasting resistance epidemiology, haematology building versus traumatology / orthopaedic building. Methods The sampling programmes were adapted according to the sampling sites and patient flow for each hospital building. Genes were quantified in the effluent using qPCR and dPCR. Cultivable carbapenemase-producing Gram-negative bacteria were characterised using MALDI-TOF MS and PCR. Results The feasibility of AMR monitoring in wastewater in real hospital conditions was demonstrated by dPCR and qPCR, which produced correlated results. The presence of peaks and the low load of the vanA and blaNDM genes in wastewater (compared to blaCTX-M) were consistent with their known emerging status, as indicated by national and local epidemiological data. However, the constant presence of blaOXA-48 and blaKPC at levels often higher than those of blaCTX-M in wastewater did not reflect the known epidemiology of these emerging resistances, particularly in the case of blaKPC. Bacterial culture also revealed discrepancies with known epidemiology, with a majority of Citrobacter spp. carrying blaKPC and blaOXA-48 in wastewater, whereas Escherichia coli and blaOXA-48 dominated in patients. Quantifying carbapenemase genes in wastewater was able to differentiate between buildings housing patients with a high or standard risk of emerging AMR. Conclusion Alongside the encouraging findings regarding patient populations and the potential predictive power of AMR WWS, this study identified obstacles that need to be overcome before it can be used for routine surveillance in an infection control hospital context.
No takes yet. Share an insight, caveat, or question.
Favier et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: